Lachlan Hanbury Brown
Stock Analyst at William Blair
(0.92)
# 2,520
Out of 4,974 analysts
138
Total ratings
44.4%
Success rate
-1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Hanbury Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | n/a | $10.19 | - | 19 | Sep 15, 2026 | |
| SRZN Surrozen | Reiterated: Buy | n/a | $17.77 | - | 2 | Sep 8, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | n/a | $11.20 | - | 7 | Aug 27, 2026 | |
| HROW Harrow | Reiterated: Buy | n/a | $33.84 | - | 21 | Aug 20, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | n/a | $4.25 | - | 28 | Aug 14, 2026 | |
| LENZ LENZ Therapeutics | Reiterated: Buy | n/a | $4.23 | - | 20 | Aug 12, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | n/a | $78.23 | - | 14 | Aug 12, 2026 | |
| KLRS Kalaris Therapeutics | Reiterated: Buy | n/a | $3.20 | - | 13 | Aug 11, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | n/a | $21.83 | - | 10 | Aug 6, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | n/a | $8.37 | - | 2 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.65 | - | 2 | Mar 16, 2026 |
Ocular Therapeutix
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.19
Upside: -
Surrozen
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.77
Upside: -
Eupraxia Pharmaceuticals Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.20
Upside: -
Harrow
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.84
Upside: -
ARS Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.25
Upside: -
LENZ Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.23
Upside: -
Tarsus Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.23
Upside: -
Kalaris Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.20
Upside: -
Viridian Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.83
Upside: -
Solid Biosciences
Mar 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.37
Upside: -
Mar 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.65
Upside: -